Standard Dose
Standard Dose is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Standard Dose.
Standard Dose is a company.
Key people at Standard Dose.
Key people at Standard Dose.
Standard Dose was a wellness e-commerce company founded in 2019 that curated and sold vetted CBD and plant-based wellness products, emphasizing transparency through rigorous lab testing and education.[1][2][3] It targeted consumers seeking high-quality, reliable CBD solutions for well-being, operating initially with a physical store in New York before pivoting to online-only during the 2020 pandemic; the company raised $2M in seed funding but ceased operations around 2023, marked as "Dead" with its website down and UK entity dissolved.[1][2][4][6] Despite early buzz post-Farm Bill legalization, it struggled with vendor payments and never reopened its brick-and-mortar location, ending with minimal activity by September 2023.[4][6]
Standard Dose was founded in January 2019 by Anthony Saniger, CEO of creative agency Act Second, launching just one month after the U.S. Farm Bill legalized hemp-derived CBD trade.[2][4] Saniger curated a selection of topical and ingestible CBD brands, vetting them via a three-pronged process: requiring lab tests from brands, followed by independent third-party verification to confirm CBD content accuracy.[2] The company gained quick media attention from outlets like Vogue, Forbes, and Well+Good, opened a three-story Manhattan store-cum-event space in September 2019 near Madison Square Park, and secured seed funding led by Lucas Brand Equity's LB Equity Emerging Growth Fund—its first investment in cannabis-related ventures.[1][4] Early traction included plans for expansion, but the COVID-19 pandemic forced store closure in 2020, shifting to e-commerce only.[4]
Standard Dose rode the explosive post-2018 Farm Bill CBD boom within the $11B+ U.S. wellness e-commerce sector, capitalizing on rising demand for transparent, plant-based alternatives amid skepticism over unverified products.[1][2][4] Its timing aligned with hemp legalization, enabling quick entry into beauty/personal care and e-commerce expert collections, but market forces like the 2020 pandemic disrupted physical retail while intensifying online competition from cannabis marketplaces (e.g., Eaze, Meadow Care).[1][4] The company highlighted early ecosystem challenges—vendor payment issues and funding hurdles—mirroring volatility in cannabis tech, where it influenced by proving demand for vetted curation but ultimately underscored scaling risks without sustained capital.[1][4]
Standard Dose's shutdown reflects the high failure rate in early CBD retail amid regulatory flux, payment woes, and post-pandemic shifts, with no revival indicated as of its 2023 dissolution.[1][4][6] Looking ahead, its model could inspire future players in a maturing $50B+ global wellness market, where AI-driven vetting and blockchain transparency address past trust gaps. Survivors may consolidate curation into larger platforms, evolving Standard Dose's transparency legacy into enduring e-commerce standards for plant-based health.
